Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Biorxiv : the Preprint Server for Biology|February 17, 2023
Ketamine evoked disruption of entorhinal and hippocampal spatial mapsFrancis Kei Masuda, Yanjun Sun, Emily A Aery Jones, et al.
Nature Communications|October 7, 2023
Ketamine evoked disruption of entorhinal and hippocampal spatial mapsFrancis Kei Masuda, Emily A Aery Jones, Yanjun Sun, et al.
Oncology Letters|August 5, 2024
Tumor antigen‑specific interleukin‑10‑producing T‑cell response in patients with head and neck squamous cell carcinomaMomoka Horikawa, Kei Masuda, Hideyuki Takahashi, et al.
Journal of Medicinal Chemistry|January 6, 2021
Discovery of a Novel and Brain-Penetrant O-GlcNAcase Inhibitor via Virtual Screening, Structure-Based Analysis, and Rational Lead OptimizationMichiko Tawada, Makoto Fushimi, Kei Masuda, et al.
Anticancer Research|October 30, 2024
Clinical Significance of FAM83G in Breast Cancer: Association With Triple-negative Subtype and PrognosisTakako Ikeda, Chikako Kanno Honda, Sasagu Kurozumi, et al.
Journal of Materials Science. Materials in Medicine|May 17, 2021
In vitro assessment of antitumor immune responses using tumor antigen proteins produced by transgenic silkwormsKanae Yamada, Kei Masuda, Shota Ida, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|September 25, 2012
Effects of transdermal tulobuterol in pediatric asthma patients on long-term leukotriene receptor antagonist therapy: results of a randomized, open-label, multicenter clinical trial in Japanese children aged 4-12 yearsToshio Katsunuma, Takao Fujisawa, Mizuho Nagao, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|September 26, 2017
Effects of Transdermal Tulobuterol in Pediatric Asthma Patients on Long-Term Leukotriene Receptor Antagonist Therapy: Results of a Randomized, Open-Label, Multicenter Clinical Trial in Japanese Children Aged 4-12 YearsToshio Katsunuma, Takao Fujisawa, Nagao Mizuho, et al.
Molecular and Clinical Oncology|October 21, 2021
Prognostic value of tumor-infiltrating lymphocytes in estrogen receptor-positive and human epidermal growth factor receptor 2-negative breast cancerChikako Honda, Sasagu Kurozumi, Ayaka Katayama, et al.
Pageof 2